Skip to main content
    D

    Danaher Corporation (DHR)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $230.11
    -2.91 (-1.25%)

    Market Cap: $163.94B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Danaher Corporation (DHR) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Danaher (DHR) trades at 27.6x trailing earnings and 6.3x sales. Its P/E of 27.6x is above its 5-year median of 26.8x. Its forward P/E is 24.9x. The median P/E across 11 similar companies is 28.5x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 10.8% higher over the next year. Its free cash flow yield is 3.5%.

    MultipleValue
    P/E (trailing)27.6x
    Forward P/E24.9x
    Price to sales6.3x
    Price to book3.0x
    EV/EBITDA23.4x
    Price to FCF28.3x
    EV/FCF31.9x
    PEG1.3
    FCF yield3.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 1.5% above 27.2x, its P/S is 3.1% below 6.5x and its P/B is 6.3% below 3.2x.

    MultipleCurrent5-year median10-year median
    P/E27.6x26.8x27.2x
    P/S6.3x7.1x6.5x
    P/B3.0x3.4x3.2x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 18.3x in 2016 to 35.3x in 2020.

    Year endPriceP/EP/SP/B
    2025$228.9229.3x6.6x3.1x
    2024$229.5530.6x7.1x3.4x
    2023$231.3427.2x7.1x3.2x
    2022$265.4224.2x7.2x4.0x
    2021$329.0132.7x9.5x5.4x
    2020$222.1435.3x7.1x4.0x
    2019$153.4832.7x6.2x3.7x
    2018$103.1222.8x4.2x2.6x
    2017$92.8223.0x4.2x2.5x
    2016$77.8418.3x3.2x2.4x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DHR

    What is DHR's forward P/E ratio?

    Danaher has a forward P/E ratio of 24.9x.

    Is DHR stock overvalued?

    GNG's valuation label for DHR is Undervalued. Its P/E of 27.6x compares with a median of 28.5x across 11 similar companies.

    What is DHR's price to sales ratio?

    Danaher has a price to sales ratio of 6.3x.

    What is Danaher's average P/E ratio over 5 years?

    Danaher's median P/E over the last 5 years is 26.8x, from 60 month-end values through Oct 2026.

    What is DHR's PEG ratio?

    Danaher has a PEG ratio of 1.3.